# Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

> **NCT00246857** · — · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 5000 (estimated)

## Conditions studied

- Primary Immune Deficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00246857
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2007-02-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00246857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00246857, "Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00246857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*